NASDAQ Rheumatology Market News

Anthera Pharmaceuticals Announces Appointment of Dr. William Shanahan Jr. as Chief Medical Officer

HAYWARD, Calif., Aug. 16, 2016 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) today announced ...

2016 ACR/ARHP ANNUAL MEETING PRESS REGISTRATION OPEN

ATLANTA, Aug. 11, 2016 (GLOBE NEWSWIRE) -- The American College of Rheumatology (ACR) and ...

Apricus Biosciences Provides Corporate Update and Second Quarter Financial Results

Strategic Focus on Growing Global Vitaros® Revenue and Achieving Profitability in 2017Apricus Granted Type ...

Anthera Pharmaceuticals Announces Completion of Dosing in CHABLIS-SC1 Phase 3 Clinical Study with Blisibimod

HAYWARD, Calif., Aug. 03, 2016 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq:ANTH) today announced that ...

Apricus Biosciences to Present at the Canaccord Genuity 36th Annual Growth Conference

SAN DIEGO, Aug. 03, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...